is semaglutide fda approved for mash GLP-1 BREAKTHROUGH: APPROVES TREATMENT SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, now the first GLP-1 therapy to treat (Metabolic Dysfunction–Associated Semaglutide as a MASH Treatment:

Taking Contrave Administration: Oral tablets taken twice daily Morning and evening dosing Can be taken with or without food Swallow whole (dont crush, chew, or cut) Titration schedule: Week 1: One tablet in the morning Week 2: One tablet morning, one evening Week 3: Two tablets morning, one evening Week 4 and ongoing: Two tablets morning, two evening (full dose) Daily requirements: Remember to take medication twice daily Consistent timing helps Missed dose: Skip if close to next dose

Injection site reactions typically clear within 24-48 hours

By the end of this guide, you'll have a clear picture of what GLP-1 is, how it works, and why it's becoming a game-changer in the healthcare industry

After 12 weeks, mice in the high-fat diet group were divided into two groups: the first group included the high-fat group, which continued to eat a high-fat diet

Front Microbiol 9:1264 Gopalakrishnan V et al (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy

Jrvinen A, Laine MK, Tikkanen R, et al